Loading...
RCT
ACE Report #10160
Ace Report Cover Shoulder & Elbow

AAOS2018: Additional liposomal bupivacaine infiltration to ISBPB of no benefit in TSA


Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Interscalene Brachial Plexus Blockade with and without Liposomal-Released Bupivacaine Soft Tissue Infiltration in Shoulder Arthroplasty: A Randomized Controlled Trial

Contributing Authors: S Namdari TA Nicholson JA Abboud MD Lazarus D Steinberg G Williams

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

75 patients scheduled for total shoulder arthroplasty under an interscalene brachial plexus block were randomized to either receive or not receive additional intraoperative infiltration of liposomal bupivacaine within the periarticular soft tissues. Patients were assessed for narcotic consumption over the first 24 hours after surgery, and pain scores over the first 72 hours postoperatively. Result...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.